Skip to content

Where to put $1,000 in stocks to make $10k in 2025

Where to put $1,000 in stocks to make $10k in 2025
Ana Zirojevic

While it is no secret that assets in the stock market can offer substantial profits to skillful investors and traders, it is sometimes difficult to discern which stocks are better than others in this regard and which could provide an income of, say, $10,000 from investing a mere $1,000 in them.

Indeed, while placing $1,000 in specific stocks with the goal of turning this relatively low investment into $10,000 in 2025 is exceptionally speculative and entails massive risks, Finbold has analyzed the equities market to find those to consider as a way to achieve this optimistic goal.

#1 CrowdStrike (CRWD)

Specifically, among these stocks is the prominent American cybersecurity technology company CrowdStrike (NASDAQ: CRWD), which has just received an increased price target for the next 12 months from KeyBanc, raising their CRWD stock price prediction from $300 to $345, and retaining the ‘overweight’ score.

At the same time, Needham analyst Mike Cikos also awarded CRWD stock a ‘buy’ rating and a $360 price target, after attending the company’s Fal.Con presentation, arguing that it might be able to turn the widespread IT outage from July into a catalyst for future price gains. Additionally, it is the Wall Street’s consensus that CRWD stock is a ‘strong buy’ with an average price of $325.22.

Wall Street’s Crowdstrike stock price prediction. Source: TipRanks
Wall Street’s CrowdStrike stock price prediction. Source: TipRanks

Meanwhile, the price of CRWD stock at press time stood at $298.40, reflecting a 0.22% gain on the day, an increase of 10.74% across the week, adding up to an accumulated advance of 12.26% in the last month, and 20.90% growth year-to-date (YTD), according to the most recent data on September 23.

Crowdstrike stock price year-to-date (YTD) chart. Source: Finbold
CrowdStrike stock price year-to-date (YTD) chart. Source: Finbold

#2 Hims & Hers Health (HIMS)

An expanding force in personalized healthcare solutions and telemedicine, Hims & Hers Health (NYSE: HIMS) has experienced a substantial growth of 52% year-over-year (YoY) in the second quarter of 2024, reaching $316 million and amassing over 1.9 million subscribers to its total user base.

In late August, Needham analysts initiated coverage of Hims & Hers Health stock with a ‘buy’ rating and a $24 price target, while the average Wall Street HIMS stock price prediction currently stands at $21.09, suggesting an increase of 29.39% from its price at the time of publication.

Wall Street’s HIMS stock price prediction. Source: TipRanks
Wall Street’s HIMS stock price prediction. Source: TipRanks

Meanwhile, HIMS stock was at press time trading at the price of $16.27, down 0.50% in the last 24 hours, gaining 0.16% across the previous seven days, as well as advancing 1.66% on its monthly chart while making a more significant upward move of 68.73% since the year’s turn.

Hims & Hers Health stock price year-to-date (YTD) chart. Source: Finbold
Hims & Hers Health stock price year-to-date (YTD) chart. Source: Finbold

#3 Alphabet (GOOGL)

Finally, while it is no secret that high-caps are usually among the best investment choices, Alphabet (NASDAQ: GOOGL), Google’s $2-trilion-worth parent company, has maintained its leadership position in the area of search and cloud services, and analysts remain optimistic about its long-term prospects.

Indeed, due to its ongoing push into artificial intelligence (AI), Alphabet has managed to position itself as a key player in the field, and adding the GOOGL stock’s attractive valuation of P/E ratio at 22.9 and forward P/E at 18.42, as well as the projected 14% earnings growth, justifies this optimism.

Wall Street’s GOOGL stock price prediction. Source: TipRanks
Wall Street’s GOOGL stock price prediction. Source: TipRanks

For now, the price of GOOGL stock amounts to $163.99, which suggests a 0.08% drop on its daily chart but nonetheless an increase of 2.73% in the past week, a decline of 1.28% over the month, and yet an 18.69% gain since the beginning of 2024, as per data on September 23.

GOOGL stock price year-to-date (YTD) chart. Source: Finbold
GOOGL stock price year-to-date (YTD) chart. Source: Finbold

Conclusion

Ultimately, the above stocks might, indeed, offer lucrative earning opportunities and turn a well-timed, well-placed investment of $1,000 into a whopping $10,000 in 2025. However, it is impossible to guarantee profits in such an unpredictable environment, so doing one’s own research is critical.

Best Crypto Exchange for Intermediate Traders and Investors

  • Invest in cryptocurrencies and 3,000+ other assets including stocks and precious metals.

  • 0% commission on stocks - buy in bulk or just a fraction from as little as $10. Other fees apply. For more information, visit etoro.com/trading/fees.

  • Copy top-performing traders in real time, automatically.

  • eToro USA is registered with FINRA for securities trading.

30+ million Users
Securities trading offered by eToro USA Securities, Inc. (“the BD”), member of FINRA and SIPC. Cryptocurrency offered by eToro USA LLC (“the MSB”) (NMLS: 1769299) and is not FDIC or SIPC insured. Investing involves risk, and content is provided for educational purposes only, does not imply a recommendation, and is not a guarantee of future performance. Finbold.com is not an affiliate and may be compensated if you access certain products or services offered by the MSB and/or the BD

Read Next:

Finance Digest

By subscribing you agree with Finbold T&C’s & Privacy Policy

Related posts

Sign Up

or

By submitting my information, I agree to the Privacy Policy and Terms of Service.

Already have an account? Sign In

Services

Disclaimer: The information on this website is for general informational and educational purposes only and does not constitute financial, legal, tax, or investment advice. This site does not make any financial promotions, and all content is strictly informational. By using this site, you agree to our full disclaimer and terms of use. For more information, please read our complete Global Disclaimer.